Nan Xinsheng, Hou Jianghui, Maclean Alan, Nasir Jamal, Lafuente Maria Jose, Shu Xinhua, Kriaucionis Skirmantas, Bird Adrian
Wellcome Trust Centre for Cell Biology, University of Edinburgh, The King's Buildings, Edinburgh EH9 3JR, United Kingdom.
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2709-14. doi: 10.1073/pnas.0608056104. Epub 2007 Feb 12.
Mutations in the human methyl-CpG-binding protein gene MECP2 cause the neurological disorder Rett syndrome and some cases of X-linked mental retardation (XLMR). We report that MeCP2 interacts with ATRX, a SWI2/SNF2 DNA helicase/ATPase that is mutated in ATRX syndrome (alpha-thalassemia/mental retardation, X-linked). MeCP2 can recruit the helicase domain of ATRX to heterochromatic foci in living mouse cells in a DNA methylation-dependent manner. Also, ATRX localization is disrupted in neurons of Mecp2-null mice. Point mutations within the methylated DNA-binding domain of MeCP2 that cause Rett syndrome or X-linked mental retardation inhibit its interaction with ATRX in vitro and its localization in vivo without affecting methyl-CpG binding. We propose that disruption of the MeCP2-ATRX interaction leads to pathological changes that contribute to mental retardation.
人类甲基化CpG结合蛋白基因MECP2的突变会导致神经紊乱雷特综合征以及一些X连锁智力迟钝(XLMR)病例。我们报告称,MeCP2与ATRX相互作用,ATRX是一种SWI2/SNF2 DNA解旋酶/ATP酶,在ATRX综合征(α地中海贫血/智力迟钝,X连锁)中发生突变。MeCP2能够以DNA甲基化依赖的方式将ATRX的解旋酶结构域招募到活小鼠细胞的异染色质位点。此外,在Mecp2基因敲除小鼠的神经元中,ATRX的定位被破坏。MeCP2甲基化DNA结合结构域内导致雷特综合征或X连锁智力迟钝的点突变在体外抑制其与ATRX的相互作用,在体内抑制其定位,而不影响甲基-CpG结合。我们提出,MeCP2-ATRX相互作用的破坏会导致导致智力迟钝的病理变化。